期刊文献+

连续性血液净化治疗全身炎症反应综合征的效果 被引量:3

Clinical outcomes of continuous blood purification in patients with systemic inflammatory response syndrome
原文传递
导出
摘要 目的探讨连续性静脉-静脉血液滤过(CVVH)治疗全身炎症反应综合征(SIRS)的临床效果。方法 60例SIRS患者分别采用CVVH(CVVH组,30例)和常规治疗(对照组,30例)。监测治疗前后两组患者体温、HR、RR和外周血WBC计数,ELISA法检测血清TNF-α、IL-1、IL-6和IL-8的水平,比较两组多器官功能障碍综合征(MODS)的发生率和ICU住院时间。结果治疗后,CVVH组患者血清TNF-α、IL-1、IL-6和IL-8水平的下降均快于对照组(P<0.01),体温、HR、RR和外周血WBC计数改善效果均优于对照组(P<0.01)。与对照组相比,CVVH组MODS发生率低(6.67%vs.33.33%)(P<0.01),ICU住院日少[(8.4±2.9)d vs.(13.2±4.1)d](P<0.01)。结论 CVVH可以清除SIRS患者体内过度释放的炎症因子,有效阻断SIRS向MODS发展的进程。 Objective To study the clinical outcomes of continuous venous-venous hemofiltration(CVVH)in the patients with systemic inflammatory response syndrome(SIRS).Methods Sixty patients with SIRS were randomly and equally divided into two groups of A(received CVVH treatment)and B(received conventional treatment).The changes of clinical indicators including temperature,heart rate(HR),respiratory rate(RR)and white blood cell(WBC)count were monitored and serum levels of inflammatory cytokines including TNF-α,IL-1,IL-6 and IL-8 were determined using ELISA before and after treatment.The incidence rate of multiple organ disorder syndrome(MODS)and ICU stay were compared between two groups.Results The descrease in serum levels of TNF-α,IL-1,IL-6 and IL-8 was faster in group A than that in group B(P〈0.01),and the improvements of temperature,HR,RR and WBC count were better in group A than those in group B after treatment(P〈0.01).Compared with group B,the incidence rate of MODS was lower(6.67% vs.33.33%)and ICU stay were less[(8.4±2.9)d vs.(13.2±4.1)d]in group A(P〈0.01).Conclusion CVVH treatment is able to remove the excessive release of inflammatory cytokines and effectively block the process of SIRS to MODS in the patients with SIRS.
出处 《江苏医药》 CAS 北大核心 2014年第22期2699-2702,共4页 Jiangsu Medical Journal
基金 南通市应用研究计划(BK2011073)
关键词 全身炎症反应综合征 连续性静脉-静脉血液净化 炎症因子 Systemic inflammatory response syndrome Continuous venous-venous hemofiltration Inflammatory cytokines
  • 相关文献

参考文献12

  • 1Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflamma- tion and imrnunosuppression., a common syndrome and new horizon for surgical intensive care[J]. J Trauma Acute Care Surg,2012,72(6) : 1491-1501.
  • 2Afessa B, Green B, I)elke I, et al. Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU[J]. Chest, 2001,120 (4): 1271-1277.
  • 3Zhou F, Song Q, Peng Z, et al. Effects of continuous venous- venous hemofiltration on heat stroke patients: a retrospective study[J]. J Trauma,2011,71(6) : 1562-1568.
  • 4Hongliang T,Rong Z,Xiaojing W,et al. The effects of conti- nuous blood purification for sirs/mods patients: a systematic review and recta-analysis of randomized controlled trials[J]. ISRN Hematol, 2012,2012 : 986795.
  • 5Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Commit-tee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992,101 (6) : 1644-1655.
  • 6Yamakawa K, Ogura H, Koh T, et al. Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome [J]. J Trauma Acute Care Surg,2013,74(2) :411-417.
  • 7Scott HF, Don0gbue AJ, Gaieski DF, et al. The utility of early lactate testing in undifferentiated pediatric systemic inflamma- tory response syndrome[J]. Acad Emerg Med, 2012,19 ( 11 ) : 1276-1280.
  • 8Klein Klouwenberg PM, Ong DS, Bonten MJ, et al; Classifica- tion of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria[J]. Intensive Care Med,2012,38(5):811-819.
  • 9Vlahakos D, Arkadopoulos N, Kostopanagiotou G, et al. Deferoxamine attenuates lipid peroxidation, blocks interleu- kin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs[J]. Artif Organs, 2012,36(4) : 400-408.
  • 10Bishehsari F, Sharma A, Stello K, et ak TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome(MODS) in acute pancreatitis[J]. Pancreatology, 2012,12(2) :113 -118.

同被引文献32

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部